Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Rosenfeld PJ. Optical Coherence Tomography and the Development of Antiangiogenic Therapies in Neovascular Age-Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2016;57:OCT14–26.
2. Olson J, Sharp P, Goatman K, Prescott G, Scotland G, Fleming A, et al. Improving the economic value of photographic screening for optical coherence tomography-detectable macular oedema: a prospective, multicentre, UK study. Health Technol Assess. 2013;17:1–142.
3. Food and Drug Administration. 510(k) Premarket notification, Envisu Spectral Domain Ophthalmic Imaging System (SDOIS). 2012. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfPMN/pmn.cfm?ID=K120057. Accessed 23 Aug 2020.
4. Maloney R. The Optovue iVue OCT System from Grafton Optical: the possibilities of hand-held OCT devices in ophthalmic practice. J Vis Commun Med. 2012;35:76–81.
5. Liu X, Kale AU, Capewell N, Talbot N, Ahmed S, Keane PA, et al. Optical coherence tomography (OCT) in unconscious and systemically unwell patients using a mobile OCT device: a pilot study. BMJ Open. 2019;9:e030882.
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献